0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IVF Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-37W5964
Home | Market Reports | Health| Reproductive Health
Global IVF Market Insights Forecast to 2028
BUY CHAPTERS

Global IVF Market Research Report 2023

Code: QYRE-Auto-37W5964
Report
February 2023
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global IVF Market

In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
The global IVF market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience

Report Scope

This report aims to provide a comprehensive presentation of the global market for IVF, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVF.
The IVF market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global IVF market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVF companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Vitrolife AB
  • EMD Serono Inc
  • Irvine scientific
  • Cooper Surgical Inc
  • Cook Medical Inc
  • Thermo Fisher Scientific Inc
  • Genea Biomedx
  • Auxogyn, Inc
  • Oxford Gene Technology
  • Ovascience

Segment by Type

  • Intracytoplasmic Sperm Injection (ICSI)
  • Frozen Embryo Replacement (FER)
  • Pre-implantation Genetic Diagnosis (PGD)

Segment by Application

  • Clone
  • Transgenic
  • Embryonic Stem Cell Isolation and Culture
  • Test Tube Baby

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of IVF companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global IVF Market Report

Report MetricDetails
Report NameGlobal IVF Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVF Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Intracytoplasmic Sperm Injection (ICSI)
1.2.3 Frozen Embryo Replacement (FER)
1.2.4 Pre-implantation Genetic Diagnosis (PGD)
1.3 Market by Application
1.3.1 Global IVF Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clone
1.3.3 Transgenic
1.3.4 Embryonic Stem Cell Isolation and Culture
1.3.5 Test Tube Baby
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVF Market Perspective (2018-2029)
2.2 IVF Growth Trends by Region
2.2.1 Global IVF Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 IVF Historic Market Size by Region (2018-2023)
2.2.3 IVF Forecasted Market Size by Region (2024-2029)
2.3 IVF Market Dynamics
2.3.1 IVF Industry Trends
2.3.2 IVF Market Drivers
2.3.3 IVF Market Challenges
2.3.4 IVF Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVF Players by Revenue
3.1.1 Global Top IVF Players by Revenue (2018-2023)
3.1.2 Global IVF Revenue Market Share by Players (2018-2023)
3.2 Global IVF Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVF Revenue
3.4 Global IVF Market Concentration Ratio
3.4.1 Global IVF Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVF Revenue in 2022
3.5 IVF Key Players Head office and Area Served
3.6 Key Players IVF Product Solution and Service
3.7 Date of Enter into IVF Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVF Breakdown Data by Type
4.1 Global IVF Historic Market Size by Type (2018-2023)
4.2 Global IVF Forecasted Market Size by Type (2024-2029)
5 IVF Breakdown Data by Application
5.1 Global IVF Historic Market Size by Application (2018-2023)
5.2 Global IVF Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America IVF Market Size (2018-2029)
6.2 North America IVF Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America IVF Market Size by Country (2018-2023)
6.4 North America IVF Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVF Market Size (2018-2029)
7.2 Europe IVF Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe IVF Market Size by Country (2018-2023)
7.4 Europe IVF Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVF Market Size (2018-2029)
8.2 Asia-Pacific IVF Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific IVF Market Size by Region (2018-2023)
8.4 Asia-Pacific IVF Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVF Market Size (2018-2029)
9.2 Latin America IVF Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America IVF Market Size by Country (2018-2023)
9.4 Latin America IVF Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVF Market Size (2018-2029)
10.2 Middle East & Africa IVF Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa IVF Market Size by Country (2018-2023)
10.4 Middle East & Africa IVF Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vitrolife AB
11.1.1 Vitrolife AB Company Detail
11.1.2 Vitrolife AB Business Overview
11.1.3 Vitrolife AB IVF Introduction
11.1.4 Vitrolife AB Revenue in IVF Business (2018-2023)
11.1.5 Vitrolife AB Recent Development
11.2 EMD Serono Inc
11.2.1 EMD Serono Inc Company Detail
11.2.2 EMD Serono Inc Business Overview
11.2.3 EMD Serono Inc IVF Introduction
11.2.4 EMD Serono Inc Revenue in IVF Business (2018-2023)
11.2.5 EMD Serono Inc Recent Development
11.3 Irvine scientific
11.3.1 Irvine scientific Company Detail
11.3.2 Irvine scientific Business Overview
11.3.3 Irvine scientific IVF Introduction
11.3.4 Irvine scientific Revenue in IVF Business (2018-2023)
11.3.5 Irvine scientific Recent Development
11.4 Cooper Surgical Inc
11.4.1 Cooper Surgical Inc Company Detail
11.4.2 Cooper Surgical Inc Business Overview
11.4.3 Cooper Surgical Inc IVF Introduction
11.4.4 Cooper Surgical Inc Revenue in IVF Business (2018-2023)
11.4.5 Cooper Surgical Inc Recent Development
11.5 Cook Medical Inc
11.5.1 Cook Medical Inc Company Detail
11.5.2 Cook Medical Inc Business Overview
11.5.3 Cook Medical Inc IVF Introduction
11.5.4 Cook Medical Inc Revenue in IVF Business (2018-2023)
11.5.5 Cook Medical Inc Recent Development
11.6 Thermo Fisher Scientific Inc
11.6.1 Thermo Fisher Scientific Inc Company Detail
11.6.2 Thermo Fisher Scientific Inc Business Overview
11.6.3 Thermo Fisher Scientific Inc IVF Introduction
11.6.4 Thermo Fisher Scientific Inc Revenue in IVF Business (2018-2023)
11.6.5 Thermo Fisher Scientific Inc Recent Development
11.7 Genea Biomedx
11.7.1 Genea Biomedx Company Detail
11.7.2 Genea Biomedx Business Overview
11.7.3 Genea Biomedx IVF Introduction
11.7.4 Genea Biomedx Revenue in IVF Business (2018-2023)
11.7.5 Genea Biomedx Recent Development
11.8 Auxogyn, Inc
11.8.1 Auxogyn, Inc Company Detail
11.8.2 Auxogyn, Inc Business Overview
11.8.3 Auxogyn, Inc IVF Introduction
11.8.4 Auxogyn, Inc Revenue in IVF Business (2018-2023)
11.8.5 Auxogyn, Inc Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Detail
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology IVF Introduction
11.9.4 Oxford Gene Technology Revenue in IVF Business (2018-2023)
11.9.5 Oxford Gene Technology Recent Development
11.10 Ovascience
11.10.1 Ovascience Company Detail
11.10.2 Ovascience Business Overview
11.10.3 Ovascience IVF Introduction
11.10.4 Ovascience Revenue in IVF Business (2018-2023)
11.10.5 Ovascience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global IVF Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Intracytoplasmic Sperm Injection (ICSI)
    Table 3. Key Players of Frozen Embryo Replacement (FER)
    Table 4. Key Players of Pre-implantation Genetic Diagnosis (PGD)
    Table 5. Global IVF Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global IVF Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global IVF Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global IVF Market Share by Region (2018-2023)
    Table 9. Global IVF Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global IVF Market Share by Region (2024-2029)
    Table 11. IVF Market Trends
    Table 12. IVF Market Drivers
    Table 13. IVF Market Challenges
    Table 14. IVF Market Restraints
    Table 15. Global IVF Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global IVF Market Share by Players (2018-2023)
    Table 17. Global Top IVF Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVF as of 2022)
    Table 18. Ranking of Global Top IVF Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by IVF Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players IVF Product Solution and Service
    Table 22. Date of Enter into IVF Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global IVF Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global IVF Revenue Market Share by Type (2018-2023)
    Table 26. Global IVF Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global IVF Revenue Market Share by Type (2024-2029)
    Table 28. Global IVF Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global IVF Revenue Market Share by Application (2018-2023)
    Table 30. Global IVF Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global IVF Revenue Market Share by Application (2024-2029)
    Table 32. North America IVF Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America IVF Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America IVF Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe IVF Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe IVF Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe IVF Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific IVF Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific IVF Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific IVF Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America IVF Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America IVF Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America IVF Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa IVF Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa IVF Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa IVF Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Vitrolife AB Company Detail
    Table 48. Vitrolife AB Business Overview
    Table 49. Vitrolife AB IVF Product
    Table 50. Vitrolife AB Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 51. Vitrolife AB Recent Development
    Table 52. EMD Serono Inc Company Detail
    Table 53. EMD Serono Inc Business Overview
    Table 54. EMD Serono Inc IVF Product
    Table 55. EMD Serono Inc Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 56. EMD Serono Inc Recent Development
    Table 57. Irvine scientific Company Detail
    Table 58. Irvine scientific Business Overview
    Table 59. Irvine scientific IVF Product
    Table 60. Irvine scientific Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 61. Irvine scientific Recent Development
    Table 62. Cooper Surgical Inc Company Detail
    Table 63. Cooper Surgical Inc Business Overview
    Table 64. Cooper Surgical Inc IVF Product
    Table 65. Cooper Surgical Inc Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 66. Cooper Surgical Inc Recent Development
    Table 67. Cook Medical Inc Company Detail
    Table 68. Cook Medical Inc Business Overview
    Table 69. Cook Medical Inc IVF Product
    Table 70. Cook Medical Inc Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 71. Cook Medical Inc Recent Development
    Table 72. Thermo Fisher Scientific Inc Company Detail
    Table 73. Thermo Fisher Scientific Inc Business Overview
    Table 74. Thermo Fisher Scientific Inc IVF Product
    Table 75. Thermo Fisher Scientific Inc Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 76. Thermo Fisher Scientific Inc Recent Development
    Table 77. Genea Biomedx Company Detail
    Table 78. Genea Biomedx Business Overview
    Table 79. Genea Biomedx IVF Product
    Table 80. Genea Biomedx Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 81. Genea Biomedx Recent Development
    Table 82. Auxogyn, Inc Company Detail
    Table 83. Auxogyn, Inc Business Overview
    Table 84. Auxogyn, Inc IVF Product
    Table 85. Auxogyn, Inc Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 86. Auxogyn, Inc Recent Development
    Table 87. Oxford Gene Technology Company Detail
    Table 88. Oxford Gene Technology Business Overview
    Table 89. Oxford Gene Technology IVF Product
    Table 90. Oxford Gene Technology Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 91. Oxford Gene Technology Recent Development
    Table 92. Ovascience Company Detail
    Table 93. Ovascience Business Overview
    Table 94. Ovascience IVF Product
    Table 95. Ovascience Revenue in IVF Business (2018-2023) & (US$ Million)
    Table 96. Ovascience Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global IVF Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global IVF Market Share by Type: 2022 VS 2029
    Figure 3. Intracytoplasmic Sperm Injection (ICSI) Features
    Figure 4. Frozen Embryo Replacement (FER) Features
    Figure 5. Pre-implantation Genetic Diagnosis (PGD) Features
    Figure 6. Global IVF Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global IVF Market Share by Application: 2022 VS 2029
    Figure 8. Clone Case Studies
    Figure 9. Transgenic Case Studies
    Figure 10. Embryonic Stem Cell Isolation and Culture Case Studies
    Figure 11. Test Tube Baby Case Studies
    Figure 12. IVF Report Years Considered
    Figure 13. Global IVF Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global IVF Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global IVF Market Share by Region: 2022 VS 2029
    Figure 16. Global IVF Market Share by Players in 2022
    Figure 17. Global Top IVF Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVF as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by IVF Revenue in 2022
    Figure 19. North America IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America IVF Market Share by Country (2018-2029)
    Figure 21. United States IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe IVF Market Share by Country (2018-2029)
    Figure 25. Germany IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific IVF Market Share by Region (2018-2029)
    Figure 33. China IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America IVF Market Share by Country (2018-2029)
    Figure 41. Mexico IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa IVF Market Share by Country (2018-2029)
    Figure 45. Turkey IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia IVF Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Vitrolife AB Revenue Growth Rate in IVF Business (2018-2023)
    Figure 48. EMD Serono Inc Revenue Growth Rate in IVF Business (2018-2023)
    Figure 49. Irvine scientific Revenue Growth Rate in IVF Business (2018-2023)
    Figure 50. Cooper Surgical Inc Revenue Growth Rate in IVF Business (2018-2023)
    Figure 51. Cook Medical Inc Revenue Growth Rate in IVF Business (2018-2023)
    Figure 52. Thermo Fisher Scientific Inc Revenue Growth Rate in IVF Business (2018-2023)
    Figure 53. Genea Biomedx Revenue Growth Rate in IVF Business (2018-2023)
    Figure 54. Auxogyn, Inc Revenue Growth Rate in IVF Business (2018-2023)
    Figure 55. Oxford Gene Technology Revenue Growth Rate in IVF Business (2018-2023)
    Figure 56. Ovascience Revenue Growth Rate in IVF Business (2018-2023)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS